Resistant or reduced response Gonorrhea in US Identified for first time

Feb 01, 2023 | Rebekah Horowitz

Last week, the Massachusetts Department of Public Health announced the first cases of a concerning new gonorrhea strain. The new strain shows reduced response to multiple antibiotics and another case was also found that had genetic markers that indicate a similar drug response. The clinical alert from the Massachusetts Department of Public Health can be found here.

Both cases in Massachusetts were successfully cured with ceftriaxone, the antibiotic recommended to treat gonorrhea currently. This strain of gonorrhea has been previously seen in Asia-Pacific countries and in the United Kingdom but not in the United States. To date, there has been no direct connections between the two individuals identified in the Massachusetts. The genetic marker common in these two residents has been seen in a previous case in Nevada, but that strain retained sensitivity to at least one class of antibiotics.

The Massachusetts cases were detected by DPH’s State Public Health Laboratory as part of disease surveillance activities. Field epidemiologists in DPH’s Division of Sexually Transmitted Disease Prevention are conducting contact tracing to determine if other individuals have acquired this infection. Overall, these cases are an important reminder that strains of gonorrhea in the US are becoming less responsive to a limited arsenal of antibiotics.

CDC is circulating a Dear Colleague Letter on the topic which can be found here and below are reminders on specific actions to take if there is suspicion of a gonococcal treatment failure in any patient at any anatomic site: 

  • Conduct a thorough sexual history to evaluate for possible reinfection. 
  • If reinfection has been ruled out, repeat NAAT testing at all exposed anatomic sites, along with collection of specimens for gonococcal culture and antimicrobial susceptibility testing (AST). Clinics that do not have access to culture and AST can reach out to two regional laboratories. 
  • Treating clinicians should consult a STD Clinical Prevention Training Center clinical expert or CDC for advice on obtaining cultures, antimicrobial susceptibility testing, and treatment. 
  • Presumptive treatment failures, where re-infection has been ruled out, should be reported to CDC through the local or state health department within 24 hours of diagnosis. 

About Rebekah Horowitz

More posts by Rebekah Horowitz

Related Posts

  • Public Health Informatics

Add Your Local Public Health Voice to the Future of...

Testing

Apr 29, 2025 | Gelilawit Tamrat

Add Your Local Public Health Voice to the Future of...

April podcast 2025
  • Press Release

NACCHO’s Podcast from Washington: Update on Department...

Staff at DCHHS discuss their efforts to prevent, detect, treat, and respond to...

Apr 25, 2025

NACCHO’s Podcast from Washington: Update on Department...

PPHR 600px
  • Press Release Project Public Health Ready (PPHR)

NACCHO Recognizes 22 Local Health Departments for...

Each agency has been recognized for their ability to plan for, respond to, and...

Apr 23, 2025

NACCHO Recognizes 22 Local Health Departments for...

RFA FLEXED
  • Funding Opportunity Epidemiology ID Featured Infectious Disease

Now Accepting Applications: FLEXED Learning Community...

Applications are now open through May 5 for NACCHO’s FLEXED Learning Community.

Apr 22, 2025 | Jaclyn Abramson

Now Accepting Applications: FLEXED Learning Community...

  • Press Release Partnerships

NACCHO and Metopio Announce Partnership to Empower Local...

The partnership will help local health departments access data insights to...

Apr 01, 2025

NACCHO and Metopio Announce Partnership to Empower Local...

MRC Logo
  • Press Release Medical Reserve Corps

NACCHO Announces Medical Reserve Corps Operational...

These awards will build the operational readiness capabilities of MRC units.

Mar 31, 2025

NACCHO Announces Medical Reserve Corps Operational...

Social New Episode w Special Guests 17
  • Press Release Infectious Disease Podcast

NACCHO’s Podcast from Washington: How Lubbock Public...

Lubbock Public Health in Texas, joins NACCHO to discuss the recent measles...

Mar 21, 2025

NACCHO’s Podcast from Washington: How Lubbock Public...

Social New Episode w Special Guests 15
  • Press Release Podcast Research & Reports

NACCHO’s Podcast from Washington: New Online Dashboard...

NACCHO announces the release of the new Profile Study Dashboard.

Feb 14, 2025

NACCHO’s Podcast from Washington: New Online Dashboard...

RFP IPC Facilitator 2
  • Funding Opportunity Healthcare-Associated Infections ID Featured Infection, Prevention, and Control

Request for Proposals: Facilitator for Infection...

NACCHO is seeking a skilled facilitator to lead two one-day, in-person...

Feb 10, 2025 | Jaclyn Abramson

Request for Proposals: Facilitator for Infection...

Back to Top